Maves (Homera Health) vs Vytora Health
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Maves (Homera Health)
Best for $99 first-month semaglutide with men's-health and body-optimization framingStarting at $99/mo
Vytora Health
Best for compounded or brand-name GLP-1 with named pharmacy partners, 50 statesStarting at $150/mo
Side-by-Side Comparison
| Feature | Maves (Homera Health) | Vytora Health |
|---|---|---|
| Overall Score | 7.6/10 | ✓8.7/10 |
| Starting Price | ✓$99/mo | $150/mo |
| Editorial Rating | 3.8 ★ /5 | ✓4.4 ★ /5 |
| Features | 7 features | ✓8 features |
| States Available | 50 | ✓51 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | — | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
Maves (Homera Health)
Pros
- ✓LegitScript Certified
- ✓Publishes the FDA compounded-medication disclaimer
- ✓$99/mo first-month intro pricing on semaglutide — among the most aggressive we track
- ✓All 50 states covered, stated explicitly
- ✓Both brand (Maves) and parent (Homera Health) disclosed for accountability
- ✓All-inclusive pricing — consult, meds, clinical support, and free shipping with no hidden fees
Cons
- ✗503A pharmacy partner not named (only 'licensed U.S. pharmacies')
- ✗Tirzepatide pricing not stated on the homepage — only listed as an offering
- ✗Named medical director / clinical leadership not disclosed
- ✗Refund and cancellation policy not detailed publicly
- ✗Corporate address and arbitration venue not disclosed
- ✗$99/mo is first-month only — refill/standard pricing not shown and may step up
Vytora Health
Pros
- ✓All 50 states plus DC, with per-state video-vs-audio compliance disclosed
- ✓Both compounded and brand-name options on one platform — uncommon
- ✓LegitScript Approved and HIPAA compliant
- ✓Pharmacy partners named publicly: Vials Pharmacy (TX) and Greenwich Biosciences
- ✓Operating entity disclosed: Wasef Health, PC (Pinellas Park, FL)
- ✓Competitive monthly pricing ($180 sema / $249 tirz) plus a 3-month bundle saving 17%
- ✓Brand-name Mounjaro and Zepbound available at $1,399/mo for FDA-approved options
Cons
- ✗Brand-name Mounjaro/Zepbound at $1,399/mo is near retail — insured patients may do better via LillyDirect Self Pay ($449-$699/mo)
- ✗Compounded tirzepatide at $249/mo is mid-market, above the $149-199 floor
- ✗Dose tiers aren't broken out — 'all doses included' means low-dose patients pay the same as high-dose
- ✗Initial consultation cost not shown on the public pricing page
- ✗Limited per-prescriber state licensure detail
Our Verdict
Vytora Health edges out Maves (Homera Health) with a higher overall score of 8.7/10 and is particularly strong for compounded or brand-name GLP-1 with named pharmacy partners, 50 states. Maves (Homera Health) remains a solid alternative, especially if you're looking for $99 first-month semaglutide with men's-health and body-optimization framing.
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Related comparisons
Continue exploring Maves (Homera Health) and Vytora Health head-to-heads in the same category.
- Maves (Homera Health) vs CoreAge Rx
- Maves (Homera Health) vs TrimRx
- Maves (Homera Health) vs Amazon One Medical
- Vytora Health vs NovoCare Pharmacy
- Vytora Health vs Enhance MD
- Vytora Health vs Noom Med
Or see the full category ranking.
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.